CareTrust REIT (7XC) AI Stock Analysis
CareTrust REIT
(Frankfurt:7XC)
No summary available
CareTrust REIT (7XC) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 8.60B
- Dividend Yield
- 4.11%
- Average Volume (3M)
- 77
- Price to Earnings (P/E)
- 22.6
- Beta (1Y)
- 0.24
- Revenue Growth
- 42.91%
- EPS Growth
- 23.48%
- Country
- Germany
- Employees
- 43
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- REIT - Healthcare Facilities
CareTrust REIT Business Overview & Revenue Model
Company Description
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, sen...
CareTrust REIT Earnings Call Summary
The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
CareTrust raised full-year 2026 guidance, now projecting normalized FFO per share of $2.03–$2.06 and normalized FAD per share of $2.01–$2.04 (midpoint implying ~16.2% FFO/share and ~15.1% FAD/share growth vs. 2025) based on a weighted average diluted share count of 233 million; the outlook assumes no new investments/loans/dispositions or debt/equity issuances beyond year‑to‑date activity, 2.5% inflation-based rent escalators on long‑term triple‑net leases, $147 million of loans to be repaid during the year (≈$104 million received to date), and no material change in GBP/USD. The company noted ample liquidity to fund guidance with roughly $1.4 billion available (≈$90 million cash, $605 million revolver availability on a $1.2 billion facility, ≈$671 million unsettled equity forwards and ≈$785.8 million ATM capacity), a net debt to annualized normalized run‑rate EBITDA of 1.0x, fixed charge coverage of 9.9x, and no scheduled debt maturities before 2028.
CareTrust REIT Risk Analysis
CareTrust REIT disclosed 50 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskCareTrust REIT Peers Comparison
Overall Rating
LTC80Outperform
OHI80Outperform
NHI68Neutral
SBRA65Neutral
STRW65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | $2.41B | 15.87 | 12.28% | 5.09% | 59.94% | 49.34% | |
| 80Outperform | $14.24B | 16.26 | 16.51% | 5.73% | 15.18% | 72.69% | |
| 68Neutral | $3.29B | 19.32 | 10.96% | 5.52% | 23.77% | 10.04% | |
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| 65Neutral | $5.04B | 74.77 | 2.34% | 6.08% | 18.43% | -65.50% | |
| 65Neutral | $710.14M | 19.83 | 72.36% | 5.20% | 18.27% | 6.18% |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:7XC | CareTrust REIT | 32.20 | 3.00 | 10.26% | |
| LTC | Ltc Properties | 44.75 | 11.40 | 34.17% | |
| NHI | National Health Investors | 67.04 | -4.09 | -5.74% | |
| OHI | Omega Healthcare Investors | 46.98 | 6.76 | 16.80% | |
| SBRA | Sabra Healthcare Reit | 19.74 | 2.90 | 17.21% | |
| STRW | Strawberry Fields REIT Inc | 12.69 | 1.70 | 15.42% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.